MIRA Pharmaceuticals Statistics
Total Valuation
MIRA has a market cap or net worth of $19.81 million. The enterprise value is $16.98 million.
| Market Cap | 19.81M |
| Enterprise Value | 16.98M |
Important Dates
The next estimated earnings date is Monday, November 11, 2024, before market open.
| Earnings Date | Nov 11, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
MIRA has 14.78 million shares outstanding. The number of shares has increased by 9.13% in one year.
| Shares Outstanding | 14.78M |
| Shares Change (YoY) | +9.13% |
| Shares Change (QoQ) | -25.00% |
| Owned by Insiders (%) | 18.70% |
| Owned by Institutions (%) | 4.88% |
| Float | 9.48M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 8.93 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.68
| Current Ratio | 3.68 |
| Quick Ratio | 3.54 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -3.08 |
Financial Efficiency
Return on equity (ROE) is -748.59% and return on invested capital (ROIC) is -227.19%.
| Return on Equity (ROE) | -748.59% |
| Return on Assets (ROA) | -177.53% |
| Return on Capital (ROIC) | -227.19% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$4.26M |
| Employee Count | 3 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -77.29% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -77.29% |
| 50-Day Moving Average | 1.73 |
| 200-Day Moving Average | 1.27 |
| Relative Strength Index (RSI) | 40.22 |
| Average Volume (20 Days) | 2,381,097 |
Short Selling Information
The latest short interest is 593,888, so 4.02% of the outstanding shares have been sold short.
| Short Interest | 593,888 |
| Short Previous Month | 372,410 |
| Short % of Shares Out | 4.02% |
| Short % of Float | 6.27% |
| Short Ratio (days to cover) | 0.03 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -9.72M |
| Pretax Income | -12.36M |
| Net Income | -12.78M |
| EBITDA | n/a |
| EBIT | -9.72M |
| Earnings Per Share (EPS) | -$0.66 |
Balance Sheet
| Cash & Cash Equivalents | 2.82M |
| Total Debt | n/a |
| Net Cash | 2.82M |
| Net Cash Per Share | $0.19 |
| Equity (Book Value) | 2.22M |
| Book Value Per Share | 0.15 |
| Working Capital | 2.14M |
Cash Flow
| Operating Cash Flow | -4.71M |
| Capital Expenditures | n/a |
| Free Cash Flow | -4.71M |
| FCF Per Share | -$0.32 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
MIRA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -9.13% |
| Shareholder Yield | -9.13% |
| Earnings Yield | -64.55% |
| FCF Yield | -23.78% |
Analyst Forecast
The average price target for MIRA is $11.00, which is 720.90% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $11.00 |
| Price Target Difference | 720.90% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |